Spinal Cord Injury Changes Cytokine Transport

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• The blood-brain barrier (BBB) restricts the entry of large molecules like cytokines and neurotrophic factors into the central nervous system (CNS).
• Specific transport systems facilitate the permeation of some cytokines and neurotrophic factors across the BBB.
• Pathophysiological conditions, such as spinal cord injury (SCI), can alter BBB permeability and transport system regulation.

Purpose of the Study:

• To review the pharmacokinetics of native cytokines and neurotrophic peptides/proteins across the BBB.
• To examine strategies for enhancing CNS delivery of these molecules via conjugation.
• To understand how pathophysiological conditions, especially SCI, modify BBB transport of these critical molecules.

Main Methods:

• Pharmacokinetic analysis of cytokines and neurotrophic peptides/proteins in mice after intravenous administration and in situ brain perfusion.
• Review of studies on conjugated proteins designed to improve BBB penetration.
• Analysis of regulatory changes in BBB transport systems under pathophysiological conditions, particularly after SCI.

Main Results:

• Some cytokines and neurotrophic factors utilize specific transport systems to cross the BBB.
• SCI induces time- and region-specific alterations in BBB permeability and transport systems.
• Tumor necrosis factor-alpha's entry into the CNS after SCI is mediated by upregulated transport, distinct from general BBB disruption.

Conclusions:

• Cytokine and neurotrophic factor permeation across the BBB is primarily mediated by specific transport systems.
• Regulation of these transport systems under pathological conditions significantly influences neuroinflammation and neuroregeneration outcomes.
• Understanding these transport dynamics is crucial for developing therapeutic strategies targeting CNS diseases.